Summary
Definition
History and exam
Other diagnostic factors
- GI symptoms
- symptom duration >3 months
- ascites
- abdominal distention
- pleural effusion
Risk factors
- BRCA1 mutation
- BRCA2 mutation
- increasing age
- FHx ovarian cancer
- FHx breast cancer
- never used OCP
- nulliparity
- obesity
- hormone therapy
- Lynch II syndrome
Diagnostic investigations
Treatment algorithm
Contributors
Authors VIEW ALL
Director
Gynecologic Oncology and Robotic Surgery
Cancer Treatment Centers of America
Eastern Regional Medical Center
Philadelphia
PA
Disclosures
JCC declares that he has no competing interests.
Dr Justin C. Chura would like to gratefully acknowledge Dr Allison E. Axtell, the previous contributor to this monograph. AEA declares that she has no competing interests.
Peer reviewers VIEW ALL
Chairman
Obstetrics and Gynecology
Northeast Ohio Universities of Medicine (NEOMED)
Rootstown
OH
Disclosures
MPH declares that he has no competing interests.
Gynecologic Oncology Fellow
Johns Hopkins Medical Institutions
Baltimore
MD
Disclosures
RS declares that she has no competing interests.
Associate Professor
Chief, Gynecologic Oncology
Department of Obstetrics & Gynecology (UCD)
University of Colorado Cancer Center
Aurora
CO
Disclosures
SAD declares that she has no competing interests.
Consultant Gynaecological Oncologist
Northern Gynaecological Oncology Centre
Queen Elizabeth Hospital
Gateshead
UK
Disclosures
KG is co-author of a systematic review (in print) of follow-up strategies after primary treatment in ovarian cancer. This is not referenced in this monograph.
Use of this content is subject to our disclaimer